LUCD

1.14

3.64% 0.04

Vorhandelsmarkt: 1.14

Lucid Diagnostics Inc (LUCD)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

$1.10

Offen:

$1.11

24-Stunden-Volumen:

980.45K

Relative Volume:

0.94

Marktkapitalisierung:

$149.45M

Einnahmen:

$4.35M

Nettoeinkommen (Verlust:

$-45.53M

KGV:

-1.0556

EPS:

-1.08

Netto-Cashflow:

$-44.79M

1W Leistung:

+9.62%

1M Leistung:

+8.57%

6M Leistung:

-12.31%

1J Leistung:

+44.54%

1-Tages-Spanne:

$1.0912

$1.16

1-Wochen-Bereich:

$1.02

$1.16

52-Wochen-Spanne:

$0.7501

$1.80

Lucid Diagnostics Inc Stock (LUCD) Company Profile

Firmenname

Lucid Diagnostics Inc

Sektor

Healthcare (1124)

Branche

Medical Devices (143)

Telefon

212 949 4319

Adresse

360 MADISON AVENUE, NEW YORK

Mitarbeiter

Twitter

Nächster Verdiensttermin

2025-03-24

Neueste SEC-Einreichungen

LUCD's Discussions on Twitter

Vergleichen Sie LUCD mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
LUCD Lucid Diagnostics Inc	1.14	144.21M	4.35M	-45.53M	-44.79M	-1.08
ABT Abbott Laboratories	122.55	210.84B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	92.70	137.17B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	353.80	133.55B	24.38B	2.94B	4.07B	7.6159
MDT Medtronic Plc	100.77	127.71B	34.76B	4.79B	5.21B	3.7017
EW Edwards Lifesciences Corp	83.92	48.33B	5.88B	1.34B	799.60M	2.3489

Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2021-12-27	Eingeleitet	Ascendiant Capital Markets	Buy
2021-11-08	Eingeleitet	BTIG Research	Buy
2021-11-08	Eingeleitet	Cantor Fitzgerald	Overweight
2021-11-08	Eingeleitet	Needham	Buy

Lucid Diagnostics Inc Aktie (LUCD) Neueste Nachrichten

Dec 10, 2025

Lucid Diagnostics Stock (LUCD) Opinions on Recent Clinical Data Release - Quiver Quantitative

Dec 10, 2025

Lucid Diagnostics stock price target raised to $8.25 at Ascendiant Capital By Investing.com - Investing.com South Africa

Dec 10, 2025

Lucid Diagnostics stock price target raised to $8.25 at Ascendiant Capital - Investing.com India

Dec 10, 2025

Dec 09, 2025

Lucid Diagnostics reports real-world data on esophageal test device By Investing.com - Investing.com Nigeria

Dec 09, 2025

Lucid Diagnostics (LUCD) Stock: Surge After Real-World EsoGuard Data Breakthrough! - parameter.io

Dec 09, 2025

Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection - PR Newswire

Dec 09, 2025

Dec 08, 2025

Lucid Diagnostics files for $175 mln mixed securities shelf offering - MSN

Dec 08, 2025

Dec 05, 2025

Lucid Diagnostics Announces $15.3 Million Registered Direct Offe - GuruFocus

Dec 05, 2025

Dec 04, 2025

A Look at Lucid Diagnostics Inc (LUCD) Shares in the Recent Past Indicates Growth - Setenews

Dec 04, 2025

Should I hold or sell Lucid Diagnostics Inc. stock in 2025Weekly Market Outlook & Weekly High Return Stock Opportunities - Newser

Dec 04, 2025

Dec 03, 2025

Why Lucid Diagnostics Inc. stock appeals to analysts2025 Retail Activity & Safe Investment Capital Preservation Plans - Newser

Dec 03, 2025

Dec 02, 2025

Lucid Diagnostics (LUCD) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 02, 2025

Dec 01, 2025

Lucid Diagnostics stock falls after pricing capital raise of $15M via stock offering - MSN

Dec 01, 2025

Nov 29, 2025

Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest shareholders are individual investors with 38% ownership, public companies own 30% - Yahoo Finance

Nov 29, 2025

Nov 28, 2025

Is Lucid Diagnostics Inc (LUCD) positioned for future growth? - Setenews

Nov 28, 2025

Nov 25, 2025

Why Being Public Gave PavMed a Competitive Edge - Medical Device and Diagnostic industry

Nov 25, 2025

Nov 20, 2025

Get in on Lucid Diagnostics Inc’s (LUCD) buy-in window today! - Setenews

Nov 20, 2025

Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree - PR Newswire

Nov 20, 2025

Ranking Lucid Diagnostics Inc. among high performing stocks via tools2025 Top Decliners & AI Powered Trade Plan Recommendations - newser.com

Nov 20, 2025

Lucid Diagnostics stock maintains Overweight rating at Cantor Fitzgerald By Investing.com - Investing.com Canada

Nov 20, 2025

Nov 19, 2025

Developing predictive dashboards with Lucid Diagnostics Inc. dataBear Alert & Fast Gain Swing Alerts - newser.com

Nov 19, 2025

Lucid Diagnostics stock maintains Overweight rating at Cantor Fitzgerald - Investing.com

Nov 19, 2025

Live market analysis of Lucid Diagnostics Inc.Weekly Market Report & Long Hold Capital Preservation Tips - newser.com

Nov 19, 2025

Nov 18, 2025

Why retail investors favor Lucid Diagnostics Inc. stockAnalyst Downgrade & Stock Portfolio Risk Control - newser.com

Nov 18, 2025

Is Lucid Diagnostics Inc. stock oversold or undervaluedMarket Growth Report & Pattern Based Trade Signal System - newser.com

Nov 18, 2025

Combining machine learning predictions for Lucid Diagnostics Inc.2025 Major Catalysts & Daily Volume Surge Trade Alerts - newser.com

Nov 16, 2025

Why Lucid Diagnostics Inc. stock is considered a top pickJuly 2025 Momentum & Community Consensus Picks - newser.com

Nov 16, 2025

Is Lucid Diagnostics Inc. meeting your algorithmic filter criteriaEarnings Performance Report & Weekly Momentum Stock Picks - newser.com

Nov 16, 2025

Lucid Diagnostics (NASDAQ:LUCD) Cut to Sell at Wall Street Zen - MarketBeat

Nov 16, 2025

Nov 15, 2025

Earnings call transcript: Lucid Diagnostics Q3 2025 reports revenue growth and strategic advancements - Investing.com Nigeria

Nov 15, 2025

Nov 14, 2025

Lucid Diagnostics Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:LUCD) 2025-11-14 - Seeking Alpha

Nov 14, 2025

Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - Eastern Progress

Nov 14, 2025

How supply chain issues affect Lucid Diagnostics Inc. stockJuly 2025 Setups & Daily Profit Focused Screening - Fundação Cultural do Pará

Nov 14, 2025

[New] Lucid Stock Price Prediction 2024, 2025 To 2050 - Exla Resources

Nov 14, 2025

Nov 13, 2025